Post navigation
- Persistence with once-weekly glucagon-like peptide 1 receptor agonist therapy decreases the risk of major adverse cardiovascular events: a retrospective analysis of patients with type 2 diabetes mellitus and atherosclerotic cardiovascular disease
- Save the Date Webinar “I nuovi Annali AMD 2024” – 28 maggio 2025